Detalhe da pesquisa
1.
Recruitment and activation of type 3 innate lymphoid cells promote antitumor immune responses.
Nat Immunol
; 23(2): 262-274, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35102345
2.
The receptor NLRP3 is a transcriptional regulator of TH2 differentiation.
Nat Immunol
; 16(8): 859-70, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26098997
3.
The transcription factor IRF1 dictates the IL-21-dependent anticancer functions of TH9 cells.
Nat Immunol
; 15(8): 758-66, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24973819
4.
Corrigendum: The receptor NLRP3 is a transcriptional regulator of TH2 differentiation.
Nat Immunol
; 16(12): 1292, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26580508
5.
NLRP6 negatively regulates type 2 immune responses in mice.
Allergy
; 77(11): 3320-3336, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35615773
6.
Stat3 and Gfi-1 transcription factors control Th17 cell immunosuppressive activity via the regulation of ectonucleotidase expression.
Immunity
; 36(3): 362-73, 2012 Mar 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-22406269
7.
Transcriptional expression of 8 genes predicts pathological response to first-line docetaxel + trastuzumab-based neoadjuvant chemotherapy.
BMC Cancer
; 15: 169, 2015 Mar 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-25879949
8.
Transcriptional regulation of the survivin gene.
Mol Biol Rep
; 41(1): 233-40, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24197699
9.
Valrubicin-loaded immunoliposomes for specific vesicle-mediated cell death in the treatment of hematological cancers.
Cell Death Dis
; 15(5): 328, 2024 May 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38734740
10.
Canonical and non-canonical functions of NLRP3.
J Adv Res
; 53: 137-151, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36610670
11.
GTN Enhances Antitumor Effects of Doxorubicin in TNBC by Targeting the Immunosuppressive Activity of PMN-MDSC.
Cancers (Basel)
; 15(12)2023 Jun 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37370739
12.
Re-education of myeloid immune cells to reduce regulatory T cell expansion and impede breast cancer progression.
bioRxiv
; 2023 Aug 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37645737
13.
Role of Cytokines and Chemokines in Angiogenesis in a Tumor Context.
Cancers (Basel)
; 14(10)2022 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35626056
14.
Alternative Splicing in Cancer and Immune Cells.
Cancers (Basel)
; 14(7)2022 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35406498
15.
Impact of Lipid Metabolism on Antitumor Immune Response.
Cancers (Basel)
; 14(7)2022 Apr 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35406621
16.
Protein Kinase Inhibitor-Mediated Immunoprophylactic and Immunotherapeutic Control of Colon Cancer.
Front Immunol
; 13: 875764, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35572581
17.
Hematopoietic Prostaglandin D2 Synthase Controls Tfh/Th2 Communication and Limits Tfh Antitumor Effects.
Cancer Immunol Res
; 10(7): 900-916, 2022 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35612500
18.
CD4 T cell-intrinsic STING signaling controls the differentiation and effector functions of TH1 and TH9 cells.
J Immunother Cancer
; 10(1)2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35091453
19.
Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice.
J Clin Invest
; 118(12): 3930-42, 2008 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19033663
20.
Modulation of CD4 T Cell Response According to Tumor Cytokine Microenvironment.
Cancers (Basel)
; 13(3)2021 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33498483